Literature DB >> 2242607

Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations.

R M Termaat1, K Brinkman, J C Nossent, A J Swaak, R J Smeenk, J H Berden.   

Abstract

Previously, we have shown that anti-DNA can bind to heparan sulphate (HS), a constituent of the glomerular basement membrane (GBM). We hypothesized that binding of anti-DNA to HS in the GBM plays a role in the onset of systemic lupus erythematosus (SLE) nephritis. To test this hypothesis we measured the anti-HS reactivity in cross-sectional and longitudinal studies of SLE patients with or without nephritis. In the transverse serum study single serum samples from 26 SLE patients were studied. We found no correlation between anti-HS reactivity and previously development of nephritis (anti-HS positive: seven out of 16 with history of nephritis, two out of 10 without nephritis). However, six of the seven anti-HS positive sera in the nephritis group were obtained within 1 month of the onset of nephritis, suggesting a temporal relationship between anti-HS reactivity and onset of nephritis. In the longitudinal serum study between six and 16 serum samples were studied from each of 10 SLE-patients. In five out of five episodes of nephritis we found anti-HS reactivity before the onset or exacerbation of the nephritis. In four non-renal manifestations anti-HS reactivity was found in only one episode; in none of the three patients who remained clinically stable did serum samples show anti-HS reactivity. Anti-HS reactivity was only found in sera positive for anti-DNA by Farr assay but the anti-HS titre was not a mere reflection of the reactivity measured in the Farr assay. This indicates that only a subpopulation of anti-DNA can bind to HS. We found a high correlation (r = 0.99) between anti-HS reactivities in plasma and serum and we conclude that anti-HS reactivity in serum samples from SLE patients is not due to in vitro complex formation during clotting. Although further prospective analysis is necessary, our data suggest that measurement of anti-HS reactivity in SLE patients might identify patients at risk for the development of nephritis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242607      PMCID: PMC1535136          DOI: 10.1111/j.1365-2249.1990.tb05438.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Cross-reactive binding patterns of monoclonal antibodies to DNA are often caused by DNA/anti-DNA immune complexes.

Authors:  K Brinkman; R M Termaat; J de Jong; H G van den Brink; J H Berden; R J Smeenk
Journal:  Res Immunol       Date:  1989 Jun-Aug

2.  Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney.

Authors:  E Raz; M Brezis; E Rosenmann; D Eilat
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

3.  Cross-reactivity of monoclonal anti-DNA antibodies with heparan sulfate is mediated via bound DNA/histone complexes.

Authors:  R M Termaat; K Brinkman; F van Gompel; L P van den Heuvel; J H Veerkamp; R J Smeenk; J H Berden
Journal:  J Autoimmun       Date:  1990-10       Impact factor: 7.094

4.  Murine monoclonal anti-DNA antibodies bind directly to glomerular antigens and form immune deposits.

Authors:  M P Madaio; J Carlson; J Cataldo; A Ucci; P Migliorini; O Pankewycz
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

5.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus.

Authors:  M H Liang; S A Socher; M G Larson; P H Schur
Journal:  Arthritis Rheum       Date:  1989-09

6.  Changes in heparan sulfate correlate with increased glomerular permeability.

Authors:  G C Groggel; J Stevenson; P Hovingh; A Linker; W A Border
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

7.  Systemic lupus erythematosus. II. Observations on the occurrence of exacerbations in the disease course: Dutch experience with 110 patients studied prospectively.

Authors:  A J Swaak; J C Nossent; W Bronsveld; A van Rooyen; E J Nieuwenhuys; L Theuns; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

8.  Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes.

Authors:  P Faaber; T P Rijke; L B van de Putte; P J Capel; J H Berden
Journal:  J Clin Invest       Date:  1986-06       Impact factor: 14.808

9.  Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis.

Authors:  T M Schmiedeke; F W Stöckl; R Weber; Y Sugisaki; S R Batsford; A Vogt
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

10.  Immunological studies concerning the nephritis of systemic lupus erythematosus.

Authors:  D Koffler; P H Schur; H G Kunkel
Journal:  J Exp Med       Date:  1967-10-01       Impact factor: 14.307

View more
  10 in total

1.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

2.  Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis.

Authors:  C Kramers; R M Termaat; E J ter Borg; M C van Bruggen; C G Kallenberg; J H Berden
Journal:  Clin Exp Immunol       Date:  1993-07       Impact factor: 4.330

Review 3.  Anti-dsDNA: choice of assay in relation to clinical value.

Authors:  R J Smeenk; H G van den Brink; K Brinkman; R M Termaat; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

4.  Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.

Authors:  C Kramers; M N Hylkema; M C van Bruggen; R van de Lagemaat; H B Dijkman; K J Assmann; R J Smeenk; J H Berden
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

5.  Ultrastructural localization of DNA in immune deposits of human lupus nephritis.

Authors:  D Malide; I Londoño; P Russo; M Bendayan
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

6.  Glomerular immune deposits in murine lupus models may contain histones.

Authors:  T Schmiedeke; F Stoeckl; S Muller; Y Sugisaki; S Batsford; R Woitas; A Vogt
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

7.  Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.

Authors:  M C van Bruggen; K Kramers; M N Hylkema; J van den Born; M A Bakker; K J Assmann; R J Smeenk; J H Berden
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

8.  No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis.

Authors:  M N Hylkema; I V Zwet; C Kramers; M C Van Bruggen; A J Swaak; J H Berden; R J Smeenk
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Structure and specificity of T cell receptors expressed by potentially pathogenic anti-DNA autoantibody-inducing T cells in human lupus.

Authors:  A Desai-Mehta; C Mao; S Rajagopalan; T Robinson; S K Datta
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

10.  Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus.

Authors:  C Mohan; S Adams; V Stanik; S K Datta
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.